Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood

American Journal of Nephrology

Volumn 28, Issue 1, 2007, Pages 83-90

  Woroniecki, Robert P ^a,b   Shatat, Ibrahim F ^a   Supe, Katarina ^a   Du, Zhongfang ^a   Kaskel, Frederick J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

Focal segmental glomerulosclerosis; Intercellular adhesion molecule 1; Protein array; Steroid resistance; Transforming growth factor 1

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; PREDNISONE; STEROID; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HIGH THROUGHPUT SCREENING; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY PARENCHYMA; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; URINARY EXCRETION; URINE LEVEL;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; COLLAGEN TYPE IV; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROTEIN ARRAY ANALYSIS; STEROIDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36249032609     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109396     Document Type: Article

References (32)

1. 1 in children with focal segmental glomerulosclerosis. Kidney Int 2002;61:90-95.
2. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978;13:159-165.
3. Hodson EM, Habashy D, Craig JC: Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 2006;19:CD003594.
4. Habib R, Kleinknecht C: The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu 1971;6:417-474.
5. Shalhoub RJ: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974;7:556-560.
6. Tejani AT, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR: Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988;33:729-734.
7. Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH: A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006;21:603-610.
8. Yap HK, Cheung W, Murugasu B, et al: Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999;10:529-537.
9. Garin EH, West L, Zheng W: Effect of interleukin-8 on glomerular sulfated compounds and albuminuria. Pediatr Nephrol 1997;11:274-279.
10. Laflam PF, Garin EH: Effect of tumor necrosis factor α and vascular permeability growth factor on albuminuria in rats. Pediatr Nephrol 2005;21:177-181.
11. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM: Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995;100:475-479.
12. van de Stolpe A, van der Saag PT: Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
13. Dal Canton A, Fuiano G, Sepe V, Caglioti A, Ferrone S: Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney Int 1992;41:951-955.
14. Lhotta K, Schlogl A, Kronenberg F, Joannidis M, Konig P: Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease. Clin Nephrol 1997;48:85-91.
15. Bottinger EP, Bitzer M: TGF-β signaling in renal disease. J Am Soc Nephrol 2002;13:2600-2610.
16. Angenendt P: Progress in protein and antibody microarray technology. Drug Discov Today 2005;10:503-511.
17. Nielsen UB, Geierstanger BH: Multiplexed sandwich assays in microarray format. J Immunol Methods 2004;290:107-120.
18. Herrod HG, Stapleton FB, Trouy RL, Roy S: Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome. Clin Exp Immunol 1983;52:581-585.
19. Matsumoto K, Osakabe K, Katayama H, Hatano M: In vitro lymphocyte dysfunction in lipoid nephrosis mediated by suppressor cells. Nephron 1982;32:270-272.
20. Wu MJ, Moorthy AV: Suppressor cell function in patients with primary glomerular disease. Clin Immunol Immunopathol 1982;22:442-447.
21. Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B: T-lymphocyte subsets in nephrotic syndrome. Kidney Int 1991;40:913-916.
22. Osakabe K, Matsumoto K: Concanavalin A-induced suppressor cell activity in lipoid nephrosis. Scand J Immunol 1981;14:161-165.
23. Dall'Aglio P, Chizzolini C, Brigati C: Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell. Proc Eur Dial Transplant Assoc 1983;19:673-678.
24. Matsumoto K, Osakabe K, Harada M, Hatano M: Impaired cell-mediated immunity in lipoid nephrosis. Nephron 1981;29:190-194.
25. Schnaper HW: The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 1989;3:101-110.
26. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-263.
27. Burke-Gaffney A, Hellewell PG: Regulation of ICAM-1 by dexamethasone in a human vascular endothelial cell line EAhy926. Am J Physiol 1996;270:C552-C561.
28. Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996;17:245-261.
29. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006;354:1387-1401.
30. Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O'toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F: Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006;38:1397-1405.
31. 1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial. J Hypertens 2005;23:657-664.
32. Saleh MT, El Wakkad AS: ICAM-1 and L-selectins; the cell adhesion molecules among children with nephrotic syndrome. Egypt Med J NRC 2003;2:35-53.